ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,197, issued on Sept. 22, was assigned to Roche Molecular Systems Inc. (Pleasanton, Calif.).

"Detection of target nucleic acid by solid-phase molography" was invented by Dieter Heindl (Munich), Igor Kozlov (Danville, Calif.), Nikolaus-Peter Stengele (Pleiskirchen, Germany), Alison Tsan (Danville, Calif.) and Volker Gatterdam (Nuesttal, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention describes methods for performing real-time PCR for detection and quantitation of target nucleic acids using tagged oligonucleotide probes and solid-phase molography."

The patent was filed on Dec. 19, 2019, under Application No. 17/633,359. ...